Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT: Melatonin in STEMI
NCT01172171Phase 2Completed
- Sponsor
- Herlev Hospital
- Start
- Jun 2013
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ST elevation myocardial infarction (STEMI) comparing Melatonin with Placebo (2 arms). Primary endpoint: Myocardial Salvage Index at Day 4. Started Jun 2013; status: completed.
02
Drugs
melatonin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01172171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172171.